Brain Cancer To Develop Articles & Analysis: Older
24 news found
Over the past decade, Alfa Chemistry has shown abundant expertise in the rapidly growing dietary supplements sector. To cater to the rising demand in this field, the company decided to add lecithin, omega fatty acids, phytosterol, and antioxidants to its already versatile functional ingredient offerings. Fully aware of the importance of lecithin in the dietary supplements industry, Alfa Chemistry ...
Clinical data demonstrating initial safety and efficacy from the RESKUE trial are being presented by Chief Medical Officer Maria Escolar, M.D., at the 29th Congress of European Society of Gene & Cell Therapy (ESGCT), October 11-14, 2022 Subjects treated with FBX-101 have shown increased galactocerebrosidase (GALC) enzyme activity in plasma and cerebrospinal fluid (CSF), normal white matter ...
FBX-101 clinical data demonstrating safety and initial efficacy from the RESKUE trial is being presented at the 2022 Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium FBX-101 is a systemic AAV gene therapy following unrelated cord blood transplantation (“UCBT”) and has been well tolerated through Day 180 FBX-101 significantly increased GALC enzyme ...
“The public currently perceives music predominantly as a medium for entertainment, but music has a much bigger footprint in human history than this. Historically, it’s served many important roles in society, from social cohesion to mother-infant bonding to healing,” say researchers who have developed a music-based brain-computer interface (BCI) that helps people struggling with ...
Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the closing of a $236 million Series D financing co-led by Mubadala Investment Company and The Column Group, along with participation from other new and existing investors. The funds will be used to advance the company’s pioneering drug discovery ...
The study is funded by the German Cancer Aid (Deutsche Krebshilfe). SIMF SRS is probably the most complex radiotherapy technique. It allows precise and time efficient treatment of patients with multiple brain metastasis (20%-40% of all cancer patients will develop brain metastasis). ...
ByRTsafe
We often hear if we choose to exercise and eat properly, our pancreas will thank us by functioning better and reduce our chances of developing Type 2 diabetes. Many of you watching your health will have heard of a list of produce referred to as the "dirty dozen." ...
(August 17, 2021—Montreal, Canada and Cincinnati, Ohio) LOK Corporation, a manufacturing agent that helps companies develop and manage their international distribution network and Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients today announced a commercial partnership to bring innovative brain scanners being developed ...
atai Life Sciences ("atai" or the "Company"), a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, has acquired a majority stake in Delaware based Psyber, a company dedicated to developing interventions to improve various mental health disorders and induce behavioural changes through brain computer interface (BCI)-enabled ...
Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH) to optimize its induced pluripotent stem cell (iPSC)-derived model of the central nervous system for drug discovery and toxicology applications. Stem Pharm’s model fills a commercial need to accurately reflect the complexity of cell ...
JAMA Network Open has published "Validation of a Machine Learning Brain Electrical Activity-Based Index to Aid in Diagnosing Concussion Among Athletes," a ground-breaking study on the accuracy of the BrainScope FDA-cleared biomarker, the Concussion Index, to indicate the likelihood and severity of concussive brain injury and to aid in evaluating an athlete's readiness to return to play. "What ...
Axial R&D Leader to Chair Day-long Session on Clinical Trials for ASD and New Therapeutics Axial Therapeutics Inc., a clinical-stage biotechnology company dedicated to building a unique class of gut-restricted therapeutics for central nervous system (CNS) disorders and conditions, today announced that A. Stewart Campbell, Ph.D., Axial’s Senior Vice President of Research and ...
Alzheimer’s awareness month, Optina Diagnostics and Wagner Macula Retina Center will Collaborate to Conduct a Clinical Study and Develop a Unique in-community Patient access Program Aimed to Identify the Causes of Memory Loss through Eye Diagnostics, November 6th 2019 Optina Diagnostics Optina Diagnostics, a world leading company in retinal imaging and artificial intelligence with a vision ...
BrainScope announced today that it has successfully completed a nearly five year, $9.9 million U.S. Department of Defense research contract supporting the development and validation of an objective marker of the presence and severity of concussion. In a large blinded validation study, the system demonstrated its ability to help clinicians assess concussion at the time of injury, reflect severity ...
Exposure of primary schoolchildren to outdoor green spaces is linked to an improvement in their cognitive development, finds a new study, which is the first of its kind. The association may be partly explained by reductions in traffic-related air pollution (TRAP) near green areas. Approximately half of the global population live in cities, and it is projected that by 2030, three of every five ...
New York, New York, June 30, 2015 -- Lauren Sciences LLC, the private New York biotechnology company developing breakthrough V-Smart™ Nanomedicines for brain diseases, announced today the award of a grant by Voices Against Brain Cancer (VABC). ...
The Natural Resources Defense Council today filed suit to block the use of a powerful, newly approved weed killer that will wreak further destruction on monarch butterfly populations already devastated by agricultural chemicals and poses risks to human health. The suit was filed in the D.C. Circuit court immediately after the Environmental Protection Agency approved the use of “Enlist ...
Acting under pressure from a Natural Resources Defense Council lawsuit, the U.S Food and Drug Administration today proposed a federal rule that, if finalized, would remove the potentially hazardous chemical triclosan from consumer body washes and hand soaps. “This is a good first step toward getting unsafe triclosan off the market,” said Mae Wu, an attorney in NRDC’s health ...
The U.S. Food and Drug Administration, under a court agreement signed yesterday, will end decades of delay and decide how to protect consumers from triclosan, a suspected endocrine disruptor linked to reproductive and developmental harm in laboratory studies. FDA first proposed in 1978 to remove triclosan from certain consumer products. But because it took no further action, the chemical has ...
Study in Mice Points to a Synergistic Relationship Between Lead Exposure and Schizophrenia Gene Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia. Scientists at Columbia University’s Mailman School of Public Health and the Johns Hopkins University School of ...